Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00069719 |
To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.
Condition | Intervention | Phase |
---|---|---|
Open-Angle Glaucoma Ocular Hypertension |
Drug: Glaucoma therapy |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | C-02-33, C-02-33 |
Study First Received: | September 30, 2003 |
Last Updated: | August 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00069719 |
Health Authority: | United States: Food and Drug Administration |
open-angle glaucoma ocular hypertension POAG |
Glaucoma Eye Diseases Glaucoma, Open-Angle |
Vascular Diseases Hypertension Ocular Hypertension |
Cardiovascular Diseases |